KMX three-lens brief
Evidence-based stock research on KMX. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 13.8pp over 30 days. · Negative free cash flow last quarterly (-$88.67M).
- Underperforming SPY by 13.8pp over 30 days.
- Negative free cash flow last quarterly (-$88.67M).
- Debt-to-equity of 318.2 — balance-sheet-heavy.
KMX closed at $38.27 (-0.73%) as of 2026-04-25. Market cap: $5.43B. P/E (trailing) 22.8. Concerns: underperforming SPY by 13.8pp over 30 days.; negative free cash flow last quarterly (-$88.67M).. Last quarter: Revenue $5.95B, net income -$120.68M, free cash flow -$88.67M.
Why three lenses on KMX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine KMXacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/KMX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath KMX brief"></iframe>